Physician profile
Selina Shah
NPI 1205995958
$11,493.88
in general payments reported to CMS, 2019-2025
15 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $3,122 · 2021: $4,224 · 2022: $2,926 · 2023: $233 · 2024: $26.36 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $9,900.00 | 2019-2022 | |
| Bioventus LLC | $433.12 | 2019-2025 | Gelsyn-3, Xcell |
| Fidia Pharma USA INC. | $358.97 | 2019-2025 | Hymovis, Triluron |
| Pacira Therapeutics, INC. | $219.38 | 2019-2021 | |
| Hydrocision, INC. | $124.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $122.99 | 2022-2025 | Zilretta, Iovera |
| Avanos Medical | $67.91 | 2019-2023 | On-Q* Pump and Accessories |
| Ossur Americas, INC. | $59.93 | 2025 | Unloader One X |
| Horizon Therapeutics Plc | $47.61 | 2019 | |
| Tenex Health INC. | $45.30 | 2019 | |
| Lilly USA, LLC | $33.54 | 2025 | Zepbound |
| Evolution Surgical, INC | $26.94 | 2022 | |
| Alexion Pharmaceuticals, INC. | $21.53 | 2019 | |
| Depuy Synthes Sales INC. | $20.26 | 2019 | |
| Konica Minolta Healthcare Americas, INC | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selina Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.